tiprankstipranks
Trending News
More News >
Adlai Nortye Ltd. Sponsored ADR (ANL)
:ANL
US Market

Adlai Nortye Ltd. Sponsored ADR (ANL) Similar Stocks

Compare
22 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Adlai Nortye Ltd. Sponsored ADR
$1.89
$69.92M
-82.44%
0 Buy
0 Hold
0 Sell
Moderate Buy
Incyte
$56.87
$10.68B
209.70
3.55%
6 Buy
11 Hold
1 Sell
Moderate Buy
Fate Therapeutics
$1.06
$105.39M
-82.18%
4 Buy
8 Hold
0 Sell
Moderate Buy
Adaptimmune Therapeutics
$0.22
$59.71M
-82.79%
3 Buy
3 Hold
1 Sell
Moderate Buy
BeiGene
$230.36
$25.17B
57.64%
12 Buy
1 Hold
0 Sell
Strong Buy
Immatics
$3.97
$491.06M
49.26
-61.81%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ANL
Adlai Nortye Ltd. Sponsored ADR
1.94
-8.62
-81.63%
INCY
Incyte
56.87
3.02
5.61%
FATE
Fate Therapeutics
1.06
-4.71
-81.63%
ADAP
Adaptimmune Therapeutics
0.22
-0.94
-81.03%
ONC
BeiGene
230.36
89.06
63.03%
IMTX
Immatics
4.14
-6.47
-60.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis